Diagmand (IVD Innovation Development and Upstream Solutions Conference)

Join Us For Our Talk

Advancing Molecular Diagnostics: Innovative Molecular Reagents for Rapid, Accessible and Patient-Centric Testing

May 28, 2025 | 17:30-18:00 Beijing Time CST | Location: Molecular POCT Forum

Join us as we explore the transformation of molecular testing from centralized laboratories to decentralized, patient-focused care, driven by groundbreaking diagnostic advancements. Discover how next-generation molecular reagents for qPCR, isothermal amplification, and NGS are paving the way for more accessible and precision medicine. Learn how leveraging alternative specimens—such as blood, urine, sputum, and stool—can streamline workflows and ensure assay stability at ambient temperatures, reducing the need for resource-intensive shipping and storage. We’ll showcase how Meridian is at the forefront of these innovations, overcoming traditional barriers and empowering diagnostic developers to accelerate the creation of sustainable solutions.

About The Speaker

Formerly employed at Takara, Zeyuan Jia is currently Meridian Life Science Molecular Business Development Manager in Beijing. With many years of experience in customer support for qPCR reagents, he brings deep technical expertise and industry insight to the role.

Join Us For Our Talk

Advanced Application of Recombinant Technology in Immunodiagnostics

May 28, 2025 | 11:00-11:20 Beijing Time CST | Location: Immunoassay Forum

The IVD industry is placing increasing emphasis on sustainability, with growing demands for energy efficiency, environmental protection, and the reduction of animal use. In the field of immunodiagnostics, a key trend is the shift from animal-derived to non-animal-derived components. Join us to learn more about the use of recombinant protein technology to produce non-animal-derived antibodies and blockers, highlighting their applications and performance in immunoassays. Through case studies and technical insights, we will explore how these alternatives support both diagnostic innovation and sustainable development in the IVD sector.

About The Speaker

Lily Song holds a Master’s degree in Veterinary Medicine from Huazhong Agricultural University. She previously served as Director of the International Business Development Department at MBL IVD and as Director of International Trade at Transgene Biotech. She is currently the Immuno Business Development Manager, with an in-depth understanding of immunoassay development.